Ivan Yanachkov

Dr. Yanachkov joined ZATA in June 2016. Prior that, he had served as a consultant for ZATA, and in collaboration with Dr. Tabatadze, led the development of the chemical methodology enabling the synthesis of ZATA’s new oligonucleotides and anti-pathogenic compounds. Also, before joining ZATA, Dr. Yanachkov served for over 15 years as Senior Scientist, Head of Quality Control, and Vise-President at CLSynthesis, Inc. (Worcester, MA), where he led the development of new drug candidates, and was a Principal Investigator of numerous Small Business Research Innovation Grants from the National Institute of Health. At ZATA, Dr. Yanachkov is in charge of all chemistry related R&D activity.